Loading
Every dated change on the records linked to Oesophageal and junctional adenocarcinoma, newest first: approvals and regulatory steps on its medicines, trials that reported, guideline versions, milestones, and when this page itself was checked. Dates come from the records; none is inferred. Orientation, not medical advice.
Perioperative FLOT improved overall survival compared with CROSS chemoradiotherapy in resectable oesophageal adenocarcinoma.
A milestone in how this cancer is treated.
A milestone in how this cancer is treated.